5-hydroxymethylcytosine has been researched along with Cervix Dysplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanoma, K; Cui, L; Hori, E; Itakura, A; Kato, K; Kato, M; Kawakami, M; Kawamura, K; Kodama, K; Matsumura, Y; Onoyama, I; Takeda, S; Yagi, H; Yahata, H; Yoshida, S | 1 |
| Balch, C; Chao, TK; Chen, CW; Chen, LY; Hsu, YW; Huang, RL; Lai, HC; Liao, CC; Mao, SP; Su, PH; Wu, TI | 1 |
2 other study(ies) available for 5-hydroxymethylcytosine and Cervix Dysplasia
| Article | Year |
|---|---|
Downregulation of 5-hydroxymethylcytosine is associated with the progression of cervical intraepithelial neoplasia.
Topics: 5-Methylcytosine; Animals; Cytidine Deaminase; DNA (Cytosine-5-)-Methyltransferase 1; Down-Regulation; Female; Humans; Mice, Inbred C57BL; Minor Histocompatibility Antigens; Mixed Function Oxygenases; Proto-Oncogene Proteins; Tumor Suppressor Protein p53; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2020 |
TET1 promotes 5hmC-dependent stemness, and inhibits a 5hmC-independent epithelial-mesenchymal transition, in cervical precancerous lesions.
Topics: 5-Methylcytosine; Animals; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; HeLa Cells; Heterografts; Humans; Mice; Mixed Function Oxygenases; Neoplastic Stem Cells; Precancerous Conditions; Proto-Oncogene Proteins; Squamous Intraepithelial Lesions of the Cervix; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vimentin; Zinc Finger E-box-Binding Homeobox 1 | 2019 |